| mammal (species unspecified) |
LD50 |
unreported |
2100mg/kg (2100mg/kg) |
? |
Indian Journal of Experimental Biology. Vol. 19, Pg. 396, 1981. |
| mouse |
LD50 |
intraperitoneal |
673mg/kg (673mg/kg) |
? |
Yakugaku Zasshi. Journal of Pharmacy. Vol. 89, Pg. 1138, 1969. |
| mouse |
LD50 |
intravenous |
1733mg/kg (1733mg/kg) |
? |
Japanese Journal of Antibiotics. Vol. 38, Pg. 137, 1985. |
| mouse |
LD50 |
oral |
2330mg/kg (2330mg/kg) |
? |
Drugs in Japan Vol. 6, Pg. 456, 1982. |
| mouse |
LD50 |
subcutaneous |
2290mg/kg (2290mg/kg) |
? |
Japanese Journal of Antibiotics. Vol. 41, Pg. 105, 1988. |
| rabbit |
LD50 |
intravenous |
1800mg/kg (1800mg/kg) |
BEHAVIORAL: EXCITEMENT |
"Proceedings of the International Symposium on Thiola, Tokyo, Japan, 1970," Osaka, Japan, Santen Pharmaceutical Co., Ltd., 1970Vol. -, Pg. 9, 1970. |
| rat |
LD50 |
intramuscular |
1630mg/kg (1630mg/kg) |
? |
United States Patent Document. Vol. #4242354, |
| rat |
LD50 |
intraperitoneal |
1400mg/kg (1400mg/kg) |
? |
Farmaco, Edizione Scientifica. Vol. 41, Pg. 758, 1986. |
| rat |
LD50 |
oral |
1300mg/kg (1300mg/kg) |
? |
Drugs in Japan Vol. 6, Pg. 456, 1982. |
| women |
TDLo |
oral |
3120mg/kg/26W (3120mg/kg) |
BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)" |
American Journal of Kidney Diseases. Vol. 19, Pg. 179, 1992. |
Xn